GlaxoSmithKline PLC News Headlines

GSK 
$47.3
*  
0.32
0.68%
Get GSK Alerts
*Delayed - data as of Sep. 16, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Glaxo, Theravance File Asthma Drug Application with FDA
6/30/2014 8:43:00 AM - Dow Jones Business News

GSK And Theravance Announce Submission Of SNDA To FDA For FF/VI In Asthma
6/30/2014 8:28:00 AM - RTT News

Glaxo's Promacta in Phase III for MDS - Analyst Blog
6/26/2014 2:30:00 PM - Zacks.com

Gilead Sciences: 7 Different Insiders Have Sold Shares This Month
6/26/2014 8:59:00 AM - Seeking Alpha

Isis Pharma Gets $1M Milestone Payment from Glaxo - Analyst Blog
6/25/2014 6:10:00 PM - Zacks.com

FDA Orders GSK to Review Its Global Manufacturing
6/24/2014 9:45:00 PM - Dow Jones Business News

FDA Orders GSK to Review Its Global Manufacturing -- Report
6/24/2014 9:28:00 PM - Dow Jones Business News

Sector Update: Healthcare
6/24/2014 8:58:52 AM - MT Newswires

Sector Update: Shares Steady Pre-Market; Vertex Surges 53% on Results of Study on Cystic Fibrosis Lung Treatment
6/24/2014 8:55:11 AM - MT Newswires

Isis Earns Milestone Payment From GlaxoSmithKline Related To ISIS-TTRRx
6/24/2014 7:22:00 AM - RTT News

Cepheid Forms Pharma Alliance to Fight Antibiotic Resistance - Analyst Blog
6/23/2014 5:45:00 PM - Zacks.com

Pre-Market Most Active for Jun 20, 2014 : ORCL, KND, SHPG, VOD, KMX, DB, QQQ, CONE, GSK, BBRY, SNY, FB
6/20/2014 8:39:52 AM - NASDAQ.com News

Vertex Pharmaceuticals-Johnson & Johnson Collaborate on Flu Drug - Analyst Blog
6/19/2014 5:00:00 PM - Zacks.com

Why I Love The NASDAQ: The Exchange's Top 10 Performers Year To Date
6/19/2014 10:07:53 AM - Martin Tillier

Novartis Submits Bexsero to FDA for Marketing Approval - Analyst Blog
6/17/2014 4:47:00 PM - Zacks.com

Glaxo's Promacta Holds Promise - Analyst Blog
6/17/2014 4:45:00 PM - Zacks.com

Ligand Pharmaceuticals - Severe Competitive Threat To Key Royalty Program And 'Going Concern' Risk Drive 100 Percent Downside
6/16/2014 5:41:00 PM - Seeking Alpha

Ligand Pharmaceuticals - Severe Competitive Threat To Key Royalty Program And 'Going Concern' Risk Drive 100 Percent Downside
6/16/2014 2:49:11 PM - SeekingAlpha

Ligand Pharmaceuticals - Severe Competitive Threat To Key Royalty Program And 'Going Concern' Risk Drive 100 Percent Downside
6/16/2014 2:49:00 PM - Seeking Alpha

6 Healthcare Dividend Dogs Dope 10% To 44% June Upsides
6/15/2014 12:41:00 AM - Seeking Alpha

J&J, ViiV Healthcare Tie Up for Single-Tablet HIV Treatment - Analyst Blog
6/13/2014 4:20:00 PM - Zacks.com

Amicus Therapeutics Still A "Show Me" Story
6/12/2014 2:11:00 PM - Seeking Alpha

Major British Companies Lead Top Guru-Held UK and Ireland Stocks
6/10/2014 7:34:55 PM - GuruFocus

Pharmacyclics' Imbruvica Under FDA Priority Review - Analyst Blog
6/10/2014 6:45:00 PM - Zacks.com

Big Pharma Looks For New Models
6/10/2014 4:02:00 PM - Seeking Alpha